Protalix BioTherapeutics Inc. (DE) (PLX) Declined -7.98% or -0.05 To Price $0.59 On Wednesday


Protalix BioTherapeutics Inc. (DE) (PLX) declined -7.98% or -0.05 to $0.59. It is close to 2.82 million shares traded, which is 438.01% compare to the average total volume 642828. The market cap of PLX is $85.90 million. The year to date change is -7.58%. The 52 week price range is from $0.48 to $1.51. Price of PLX have changed -4.99% during last week. It have changed 5.11% over last month, 3.44% over last 3 months, 9.62% over last 6 months and -55.15% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PLX is 0.68. It is 15.25% above current price. The 200-day Moving Averages for PLX is 0.69. It is 16.95% above current price. The 52-week High is 1.51. It is 155.93% from the current price. The 52-week Low is 0.48. It is -18.64% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of PLX is 8.54 on 2018-02-28. Short % to float is 3.37%. There are some statistics of PLX. It is has market cap $85.90 million. The share outstanding is 145.57 million. The average volume is 642828. The revenue is 16.77M. It has 116.03M cash and 121.72M in debt. The gross profit is 3.10M. The percent of top 15 Institution holding is 3.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PLX is 413.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PLX is -110.42%.


Tags:

Share this post